相关实验视频
Updated: Jun 27, 2026
05:59
Nasal Wipes for Influenza A Virus Detection and Isolation from Swine
Published on: December 4, 2015
9.4K
多种耐药性菌株 - - 罗马尼亚西部养猪场的实际问题
Luminita Costinar1, Corina Badea1, Adela Marcu2
1Department of Infectious Diseases and Preventive Medicine, Faculty of Veterinary Medicine, University of Life Sciences "King Mihai I", 300645 Timisoara, Romania.
Antibiotics (Basel, Switzerland)
|March 27, 2024
概括
这项研究分析了来自罗马尼亚猪的267个菌株,揭示了关键物种如Streptococcus suis的抗生素耐药性. 调查结果强调需要重新评估猪病和潜在的动物传染病风险的治疗策略.
科学领域:
- 兽医微生物学 兽医微生物学
- 抗微生物耐药性 抗微生物耐药性
- 动物感染病原体的病原体
背景情况:
- 链球菌种,包括典型的 (例如,Streptococcus suis) 和非典型的菌株 (例如,Streptococcus porcinus),在人类和动物中引起严重的感染.
- 瑞士杆菌是一种新兴的动物传染病原体,通过受污染的食品或直接接触构成风险.
- 来自牲畜的链球菌分离物中的高抗生素耐药率需要持续的监测和耐药性分析.
研究的目的:
- 调查2018年至2023年期间在罗马尼亚西部从猪中分离出来的链球菌种的分布和抗菌素耐药性模式.
- 为了识别和描述在罗马尼亚养猪场中流通的非典型链球菌种类.
- 评估这些潜在的动物感染性细菌对常用抗生素的耐药性.
主要方法:
- 从猪组织 (主要是肺和大脑) 中分离和识别了267种链球菌菌株.
- 在五年 (2018-2023) 期间对分离物进行抗菌敏感性测试.
- 遗传学分析以确定典型和非典型的链球菌种,包括SDSE,S. porcinus,S. hyovaginalis,S. pluranimalium和S. canis.
主要成果:
- 该研究确定了一系列的菌株菌株,包括首次描述罗马尼亚的非典型物种分布.
- 在Streptococcus suis分离物中观察到高耐药率对四环素,林科萨米德,宏类和氨基糖化物.
- 在肺部和脑组织中经常发现Streptococcus suis,这表明病理影响很大.
结论:
- 在罗马尼亚的养猪场中,Streptococcus物种中,特别是S. suis中,抗生素耐药性的流行是一个重大问题.
- 这些发现强调了重新评估目前对猪链球菌感染的治疗方案的重要性.
- 这项研究提供了关于潜在的动物性传染性非典型菌株菌株物种及其耐药性的关键数据,为公共卫生和兽医战略提供了信息.
相关概念视频
00:57Antibiotic Selection
Overview
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...